Hims & Hers CEO Dismisses FTC Lawsuit as Regulatory Misunderstanding

The lawsuit, filed in July by the FTC alongside officials from Los Angeles County and Utah, centers on claims that the company improperly shared sensitive health information with third-party advertisers including Meta and Snap. Prosecutors further allege that the platform complicates subscription cancellations and processes prescription charges before patients consult with medical professionals.

Dudum dismissed these concerns, characterizing the company as an active disruptor working to rebuild traditional healthcare systems. He argued that the FTC sought a headline-grabbing confrontation rather than a constructive agreement, despite years of collaborative communication between the parties. While the company faces scrutiny over its operational practices, Dudum maintains that the primary objective remains expanding broad access to care, a mission he claims justifies the aggressive disruption of legacy medical models.